Safety and efficacy studies of liposomes in specific immunotherapy

Current Therapeutic Research - Clinical and Experimental

Volumn 60, Issue 5, 1999, Pages 278-294

  Galvain, Sylvie ^a   André, Claude ^a   Vatrinet, Christine ^a   Villet, Bertrand ^a  

^a Stallergenes SA   (France)

Author keywords

Dermatophagoides pteronyssinus; Grass pollens; Liposome; Safety; Specific immunotherapy

Indexed keywords

HOUSE DUST ALLERGEN; LIPOSOME;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DESENSITIZATION; DRUG FORMULATION; DRUG SAFETY; FEMALE; GRASS POLLEN; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRICK TEST; PRIORITY JOURNAL;

EID: 0032915280     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(99)80004-6     Document Type: Article

References (28)

1. 1. Storm G, Crommelin DJA. Liposomes: Quo vadis? PSTT. 1998;1:19-31.
2. 2. Puisieux F, Barratt G, Roblot-Treupel LR, et al. Therapeutic aspects of liposomes. In: Hanin I, Pepeu G, eds. Phospholipids: Biochemical, Pharmaceutical and Analytical Considerations. New York: Plenum, 1990;133-166.
3. 3. Gregoriadis G. Liposomes in therapeutic and preventive medicine: The development of the drug carrier concept. Ann New York Acad Sci. 1978;308:343-370.
4. 4. Allison AC, Gregoriadis G. Liposomes as immunological adjuvants. Nature. 1974;252-253.
5. 5. Gregoriadis G, Panagiotodi C. Immunoadjuvant action of liposomes: Comparison with other adjuvants. Immunol Lett. 1989;20:237-240.
6. 6. Gregoriadis G. Immunological adjuvants: A role for liposomes. Immunol Today. 1990;3: 89-97.
7. 7. Alving CR. Liposomes as carriers of antigens and adjuvants. J Immunol Methods. 1991; 140:1-13.
8. 8. Fries LF, Gordon DM, Richards RL, et al. Liposomal malaria vaccine in humans: A safe and potent adjuvant strategy. Proc Natl Acad Sci USA. 1992;89:358-362.
9. 9. Just M, Berger R, Drechsler H, et al. A single vaccination with an inactivated hepatitis A liposome vaccine induces protective antibodies after only two weeks. Vaccine. 1992;11: 737-739.
10. 10. Audera C, Ramirez J, Soler E, Carreira J. Liposomes as carriers for allergy immunotherapy. Clin Exp Allergy. 1991;21:139-144.
11. 11. McWilliam AS, Stewart GA. Production of multilamellar, small unilamellar and reverse phase liposomes containing house dust mite allergens: Potential adjuvants in immunotherapy of allergic disease. J Immunol Methods. 1989;121:53-60.
12. 12. Audera C, Ramirez J, Soler E, Carreira J. Liposomes as adjuvants in allergy immunotherapy. Allergologie. 1989;12:109.
13. 13. Gregoriadis G, Allison AC. Entrapment of proteins in liposomes prevents allergic reactions in preimmunized mice. FEBS Lett. 1974;45:71-74.
14. 14. Wagner W, Beckman K, Edinger MG, et al. Immunotherapy with allergen sequestered in liposomes. J Allergy Clin Immunol. 1984;73:118. Abstract.
15. 15. Arora N, Gangal SV. Allergens entrapped in liposomes reduce allergenicity and induce immunogenicity on repeated injection in mice. Int Arch Allergy Appl Immunol. 1990;91: 22-29.
16. 16. Arora N, Gangal SV. Immunomodulation by liposome entrapped allergen. Mol Cell Biochem. 1990;97:173-179.
17. 17. Arora N, Gangal SV. Liposomes as vehicle for allergen presentation in the immunotherapy of allergic diseases. Allergy. 1991;46:386-392.
18. 18. Arora N, Gangal SV. Efficacy of liposome entrapped allergen in down regulation of IgE response in mice. J Allergy Clin Immunol. 1992;22:35-42.
19. 19. Wallis AF. Liposomes for allergy immunotherapy? Clin Exp Allergy. 1992;22:1-2.
20. 20. Bousquet J, Hejjaoui A, Dhivert H, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract III. Systemic reactions during the rush protocol in patients suffering from asthma. J Allergy Clin Immunol. 1989;83:797-802.
21. 21. Genin I, Barratt G, Tran XT, et al. Optimization and characterization of freeze-dried multilamellar liposomes incorporating different standardized allergen extracts. Allergy. 1994;49:645-652.
22. 22. Ciprandi G, Tosca MA, Fasce L, Canonica GW. Allergen-specific conjunctival challenge in children with allergic asthma: A clinical tool. Allergy. 1994;49:489-491.
23. 23. Abelson MB, Chambers WA, Smith LM. Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis. Arch Ophthalmol. 1990;108:84-88.
24. 24. Hjorth N, Fregert S. Contact dermatitis. In: Rook A, Wilkinson DS, Ebling FJG, eds. Textbook of Dermatology. 3rd ed. Oxford, England: Blackwell Scientific Publications; 1979.
25. 25. Lachapelle JM, Frimat P, Tennstedt D, Ducombs G. eds. Dermatologie Professionnelle et de l'Environnement. Masson, 1992;114.
26. 26. Rycroft RJG, Menne T, Frosch PD, Benezra C, eds. Textbook of Contact Dermatitis. 1991. Berlin: Springer-Verlag; 1991:64-65, 222-223.
27. 27. Saperstein H, Rapaport M, Rietschel RL. Topical vitamin E as a cause of crythema multiforme-like eruption. Arch Dermatol. 1984;120:904-908.
28. 28. Girolomoni G, Pastore S, Zacchi V, et al. Phosphatidylserine enhances the ability of epidermal Langerhans cells to induce contact hypersensitivity. J Immunol. 1993;150: 4236-4243.